Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study

Aims To verify whether it is possible, in people with diabetes mellitus (DM) considered at very high cardiovascular (CV) risk, stratify this risk better and identify significant modifiable risk factor (including lifestyle habits) to help patients and clinicians improve CV prevention. Methods People...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta diabetologica 2017-02, Vol.54 (2), p.123-131
Hauptverfasser: Marzona, Irene, Avanzini, Fausto, Lucisano, Giuseppe, Tettamanti, Mauro, Baviera, Marta, Nicolucci, Antonio, Roncaglioni, Maria Carla
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 131
container_issue 2
container_start_page 123
container_title Acta diabetologica
container_volume 54
creator Marzona, Irene
Avanzini, Fausto
Lucisano, Giuseppe
Tettamanti, Mauro
Baviera, Marta
Nicolucci, Antonio
Roncaglioni, Maria Carla
description Aims To verify whether it is possible, in people with diabetes mellitus (DM) considered at very high cardiovascular (CV) risk, stratify this risk better and identify significant modifiable risk factor (including lifestyle habits) to help patients and clinicians improve CV prevention. Methods People with DM and microvascular diseases or one or more CV risk factors (hypertension, hyperlipidemia, smoking, poor dietary habits, overweight, physical inactivity) included in the Risk and Prevention study were selected. We considered the combined endpoint of non-fatal acute myocardial infarction and stroke and CV death. A multivariate Cox proportional analysis was carried out to identify relevant predictors. We also used the RECPAM method to identify subgroups of patients at higher risk. Results In our study, the rate of major CV events was lower than expected (5 % in 5 years). Predictors of CV events were age, male, sex, heart failure, previous atherosclerotic disease, atrial fibrillation, insulin treatment, high HbA1c, heart rate and other CV diseases while being physically active was protective. RECPAM analysis indicated that history of atherosclerotic diseases and a low BMI defined worse prognosis (HR 4.51 95 % CI 3.04–6.69). Among subjects with no previous atherosclerotic disease, men with HbA1c more than 8 % were at higher CV risk (HR 2.77; 95 % CI 1.86–4.14) with respect to women. Conclusions In this population, the rate of major CV events was lower than expected. This prediction model could help clinicians identify people with DM at higher CV risk and support them in achieving goals of physical activity and HbA1c.
doi_str_mv 10.1007/s00592-016-0899-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1897378619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835385384</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-d00ff830eb0807bbf59a6b8316e29f165317fe706faaee915843f8696975e1bf3</originalsourceid><addsrcrecordid>eNqNkU2L1TAUhoMozp3RH-BGAm7cVE-SpklWMgwzjjCg-LEuaXtyb8a2qUl75f4Vf62pd_xAEIRAFud530PyEPKEwQsGoF4mAGl4AawqQBtTwD2yYaXgheRC3CcbMCUUsuTmhJymdAvAuBL6ITnhSjENkm3It_OI1PY9nTBMPdKvft7RztsGZ0zUjh1tbex82NvULr2NNPr0mTrbziEmGiIdfBt_T9swTL1v7ezDmOMz3WM80J3f7n4EX9ErP3Z-3CbqYhjovEP6fi1cF72LuMdxTdIP89IdHpEHzvYJH9_dZ-TT1eXHi-vi5u3rNxfnN0VbgpyLDsA5LQAb0KCaxkljq0YLViE3jlVSMOVQQeWsRTRM6lI4XZnKKImsceKMPD_2TjF8WTDN9eBTi31vRwxLqpk2SihdMfMfqJBC51Nm9Nlf6G1Y4pgfkildGsYrtRayI5U_MaWIrp6iH2w81Azq1XF9dFxnx_XquIaceXrXvDQDdr8SP6VmgB-BlEfjFuMfq__Z-h0TDLMs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1884912679</pqid></control><display><type>article</type><title>Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Marzona, Irene ; Avanzini, Fausto ; Lucisano, Giuseppe ; Tettamanti, Mauro ; Baviera, Marta ; Nicolucci, Antonio ; Roncaglioni, Maria Carla</creator><creatorcontrib>Marzona, Irene ; Avanzini, Fausto ; Lucisano, Giuseppe ; Tettamanti, Mauro ; Baviera, Marta ; Nicolucci, Antonio ; Roncaglioni, Maria Carla ; Risk &amp; Prevention Collaborative Group</creatorcontrib><description>Aims To verify whether it is possible, in people with diabetes mellitus (DM) considered at very high cardiovascular (CV) risk, stratify this risk better and identify significant modifiable risk factor (including lifestyle habits) to help patients and clinicians improve CV prevention. Methods People with DM and microvascular diseases or one or more CV risk factors (hypertension, hyperlipidemia, smoking, poor dietary habits, overweight, physical inactivity) included in the Risk and Prevention study were selected. We considered the combined endpoint of non-fatal acute myocardial infarction and stroke and CV death. A multivariate Cox proportional analysis was carried out to identify relevant predictors. We also used the RECPAM method to identify subgroups of patients at higher risk. Results In our study, the rate of major CV events was lower than expected (5 % in 5 years). Predictors of CV events were age, male, sex, heart failure, previous atherosclerotic disease, atrial fibrillation, insulin treatment, high HbA1c, heart rate and other CV diseases while being physically active was protective. RECPAM analysis indicated that history of atherosclerotic diseases and a low BMI defined worse prognosis (HR 4.51 95 % CI 3.04–6.69). Among subjects with no previous atherosclerotic disease, men with HbA1c more than 8 % were at higher CV risk (HR 2.77; 95 % CI 1.86–4.14) with respect to women. Conclusions In this population, the rate of major CV events was lower than expected. This prediction model could help clinicians identify people with DM at higher CV risk and support them in achieving goals of physical activity and HbA1c.</description><identifier>ISSN: 0940-5429</identifier><identifier>EISSN: 1432-5233</identifier><identifier>DOI: 10.1007/s00592-016-0899-0</identifier><identifier>PMID: 27718051</identifier><identifier>CODEN: ACDAEZ</identifier><language>eng</language><publisher>Milan: Springer Milan</publisher><subject>Aged ; Cardiovascular Diseases - epidemiology ; Diabetes ; Diabetes Mellitus - epidemiology ; Diabetic Angiopathies - epidemiology ; Female ; Humans ; Internal Medicine ; Male ; Medicine ; Medicine &amp; Public Health ; Metabolic Diseases ; Middle Aged ; Multicenter Studies as Topic ; Original Article ; Randomized Controlled Trials as Topic</subject><ispartof>Acta diabetologica, 2017-02, Vol.54 (2), p.123-131</ispartof><rights>Springer-Verlag Italia 2016</rights><rights>Acta Diabetologica is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-d00ff830eb0807bbf59a6b8316e29f165317fe706faaee915843f8696975e1bf3</citedby><cites>FETCH-LOGICAL-c405t-d00ff830eb0807bbf59a6b8316e29f165317fe706faaee915843f8696975e1bf3</cites><orcidid>0000-0001-7952-8278</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00592-016-0899-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00592-016-0899-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27718051$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marzona, Irene</creatorcontrib><creatorcontrib>Avanzini, Fausto</creatorcontrib><creatorcontrib>Lucisano, Giuseppe</creatorcontrib><creatorcontrib>Tettamanti, Mauro</creatorcontrib><creatorcontrib>Baviera, Marta</creatorcontrib><creatorcontrib>Nicolucci, Antonio</creatorcontrib><creatorcontrib>Roncaglioni, Maria Carla</creatorcontrib><creatorcontrib>Risk &amp; Prevention Collaborative Group</creatorcontrib><title>Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study</title><title>Acta diabetologica</title><addtitle>Acta Diabetol</addtitle><addtitle>Acta Diabetol</addtitle><description>Aims To verify whether it is possible, in people with diabetes mellitus (DM) considered at very high cardiovascular (CV) risk, stratify this risk better and identify significant modifiable risk factor (including lifestyle habits) to help patients and clinicians improve CV prevention. Methods People with DM and microvascular diseases or one or more CV risk factors (hypertension, hyperlipidemia, smoking, poor dietary habits, overweight, physical inactivity) included in the Risk and Prevention study were selected. We considered the combined endpoint of non-fatal acute myocardial infarction and stroke and CV death. A multivariate Cox proportional analysis was carried out to identify relevant predictors. We also used the RECPAM method to identify subgroups of patients at higher risk. Results In our study, the rate of major CV events was lower than expected (5 % in 5 years). Predictors of CV events were age, male, sex, heart failure, previous atherosclerotic disease, atrial fibrillation, insulin treatment, high HbA1c, heart rate and other CV diseases while being physically active was protective. RECPAM analysis indicated that history of atherosclerotic diseases and a low BMI defined worse prognosis (HR 4.51 95 % CI 3.04–6.69). Among subjects with no previous atherosclerotic disease, men with HbA1c more than 8 % were at higher CV risk (HR 2.77; 95 % CI 1.86–4.14) with respect to women. Conclusions In this population, the rate of major CV events was lower than expected. This prediction model could help clinicians identify people with DM at higher CV risk and support them in achieving goals of physical activity and HbA1c.</description><subject>Aged</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Diabetes</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetic Angiopathies - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic Diseases</subject><subject>Middle Aged</subject><subject>Multicenter Studies as Topic</subject><subject>Original Article</subject><subject>Randomized Controlled Trials as Topic</subject><issn>0940-5429</issn><issn>1432-5233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkU2L1TAUhoMozp3RH-BGAm7cVE-SpklWMgwzjjCg-LEuaXtyb8a2qUl75f4Vf62pd_xAEIRAFud530PyEPKEwQsGoF4mAGl4AawqQBtTwD2yYaXgheRC3CcbMCUUsuTmhJymdAvAuBL6ITnhSjENkm3It_OI1PY9nTBMPdKvft7RztsGZ0zUjh1tbex82NvULr2NNPr0mTrbziEmGiIdfBt_T9swTL1v7ezDmOMz3WM80J3f7n4EX9ErP3Z-3CbqYhjovEP6fi1cF72LuMdxTdIP89IdHpEHzvYJH9_dZ-TT1eXHi-vi5u3rNxfnN0VbgpyLDsA5LQAb0KCaxkljq0YLViE3jlVSMOVQQeWsRTRM6lI4XZnKKImsceKMPD_2TjF8WTDN9eBTi31vRwxLqpk2SihdMfMfqJBC51Nm9Nlf6G1Y4pgfkildGsYrtRayI5U_MaWIrp6iH2w81Azq1XF9dFxnx_XquIaceXrXvDQDdr8SP6VmgB-BlEfjFuMfq__Z-h0TDLMs</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Marzona, Irene</creator><creator>Avanzini, Fausto</creator><creator>Lucisano, Giuseppe</creator><creator>Tettamanti, Mauro</creator><creator>Baviera, Marta</creator><creator>Nicolucci, Antonio</creator><creator>Roncaglioni, Maria Carla</creator><general>Springer Milan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7952-8278</orcidid></search><sort><creationdate>20170201</creationdate><title>Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study</title><author>Marzona, Irene ; Avanzini, Fausto ; Lucisano, Giuseppe ; Tettamanti, Mauro ; Baviera, Marta ; Nicolucci, Antonio ; Roncaglioni, Maria Carla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-d00ff830eb0807bbf59a6b8316e29f165317fe706faaee915843f8696975e1bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Diabetes</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetic Angiopathies - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic Diseases</topic><topic>Middle Aged</topic><topic>Multicenter Studies as Topic</topic><topic>Original Article</topic><topic>Randomized Controlled Trials as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marzona, Irene</creatorcontrib><creatorcontrib>Avanzini, Fausto</creatorcontrib><creatorcontrib>Lucisano, Giuseppe</creatorcontrib><creatorcontrib>Tettamanti, Mauro</creatorcontrib><creatorcontrib>Baviera, Marta</creatorcontrib><creatorcontrib>Nicolucci, Antonio</creatorcontrib><creatorcontrib>Roncaglioni, Maria Carla</creatorcontrib><creatorcontrib>Risk &amp; Prevention Collaborative Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Acta diabetologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marzona, Irene</au><au>Avanzini, Fausto</au><au>Lucisano, Giuseppe</au><au>Tettamanti, Mauro</au><au>Baviera, Marta</au><au>Nicolucci, Antonio</au><au>Roncaglioni, Maria Carla</au><aucorp>Risk &amp; Prevention Collaborative Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study</atitle><jtitle>Acta diabetologica</jtitle><stitle>Acta Diabetol</stitle><addtitle>Acta Diabetol</addtitle><date>2017-02-01</date><risdate>2017</risdate><volume>54</volume><issue>2</issue><spage>123</spage><epage>131</epage><pages>123-131</pages><issn>0940-5429</issn><eissn>1432-5233</eissn><coden>ACDAEZ</coden><abstract>Aims To verify whether it is possible, in people with diabetes mellitus (DM) considered at very high cardiovascular (CV) risk, stratify this risk better and identify significant modifiable risk factor (including lifestyle habits) to help patients and clinicians improve CV prevention. Methods People with DM and microvascular diseases or one or more CV risk factors (hypertension, hyperlipidemia, smoking, poor dietary habits, overweight, physical inactivity) included in the Risk and Prevention study were selected. We considered the combined endpoint of non-fatal acute myocardial infarction and stroke and CV death. A multivariate Cox proportional analysis was carried out to identify relevant predictors. We also used the RECPAM method to identify subgroups of patients at higher risk. Results In our study, the rate of major CV events was lower than expected (5 % in 5 years). Predictors of CV events were age, male, sex, heart failure, previous atherosclerotic disease, atrial fibrillation, insulin treatment, high HbA1c, heart rate and other CV diseases while being physically active was protective. RECPAM analysis indicated that history of atherosclerotic diseases and a low BMI defined worse prognosis (HR 4.51 95 % CI 3.04–6.69). Among subjects with no previous atherosclerotic disease, men with HbA1c more than 8 % were at higher CV risk (HR 2.77; 95 % CI 1.86–4.14) with respect to women. Conclusions In this population, the rate of major CV events was lower than expected. This prediction model could help clinicians identify people with DM at higher CV risk and support them in achieving goals of physical activity and HbA1c.</abstract><cop>Milan</cop><pub>Springer Milan</pub><pmid>27718051</pmid><doi>10.1007/s00592-016-0899-0</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7952-8278</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0940-5429
ispartof Acta diabetologica, 2017-02, Vol.54 (2), p.123-131
issn 0940-5429
1432-5233
language eng
recordid cdi_proquest_miscellaneous_1897378619
source MEDLINE; SpringerLink Journals
subjects Aged
Cardiovascular Diseases - epidemiology
Diabetes
Diabetes Mellitus - epidemiology
Diabetic Angiopathies - epidemiology
Female
Humans
Internal Medicine
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Middle Aged
Multicenter Studies as Topic
Original Article
Randomized Controlled Trials as Topic
title Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T13%3A53%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20all%20people%20with%20diabetes%20and%20cardiovascular%20risk%20factors%20or%20microvascular%20complications%20at%20very%20high%20risk?%20Findings%20from%20the%20Risk%20and%20Prevention%20Study&rft.jtitle=Acta%20diabetologica&rft.au=Marzona,%20Irene&rft.aucorp=Risk%20&%20Prevention%20Collaborative%20Group&rft.date=2017-02-01&rft.volume=54&rft.issue=2&rft.spage=123&rft.epage=131&rft.pages=123-131&rft.issn=0940-5429&rft.eissn=1432-5233&rft.coden=ACDAEZ&rft_id=info:doi/10.1007/s00592-016-0899-0&rft_dat=%3Cproquest_cross%3E1835385384%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1884912679&rft_id=info:pmid/27718051&rfr_iscdi=true